Strategic relevance
The connection between innovation themes and the organisation's clinical, commercial, operational, or portfolio priorities.
Innovation strategy
Digital Health Innovation Strategy
Convert a broad innovation ambition into a focused portfolio of decisions, capabilities, and measurable outcomes.
The decision context
Innovation activity is not the same as innovation strategy
Healthcare organisations often accumulate pilots, partnerships, and technology themes without a shared view of the decisions they are meant to support. The result is duplicated activity, unclear ownership, and a portfolio that is difficult to scale or stop.
Galen Growth builds digital health innovation strategies around business priorities, external market evidence, internal capability, and explicit build, buy, or partner choices.
What Galen Growth evaluates
Evidence organised around the decision
Capability position
What should be owned internally, accessed through partnership, acquired, or deliberately left outside the roadmap.
Portfolio coherence
Overlap, gaps, dependencies, maturity, and the balance between exploration, validation, scale, and strategic capabilities.
Decision governance
Ownership, evidence requirements, review points, and measures that determine whether initiatives progress or stop.
HealthTech Alpha evidence
Strategy grounded in what the market is actually doing
HealthTech Alpha connects market structure with venture maturity, partnership activity, evidence, investment, and exit signals. That allows strategy teams to test internal priorities against the external ecosystem and distinguish durable capability shifts from fashionable technology labels.
- Category and technology trajectories
- Partnership and acquisition patterns
- Venture maturity and evidence
- Peer strategy benchmarks
Methodology
From question to defensible action
- Align the ambition
Translate leadership priorities into a small set of decision questions and measurable strategic outcomes.
- Diagnose the position
Assess the current portfolio, internal capabilities, external market, and competitor activity.
- Choose the model
Define where to build, buy, partner, invest, or monitor based on strategic importance and execution reality.
- Govern delivery
Establish the roadmap, owners, decision gates, portfolio measures, and evidence required for scale.
Related case studies
How Galen Growth has supported these decisions
Competitive analysis in genomics for a reinsurance company
The Corporate Venture Capital (CVC) arm of a global reinsurance company wanted to, as part of their ongoing due diligence, undertake a global competitive analysis in the genomics space before committing to their selected investment target.
Shortlisting ventures for cardio remote monitoring
A global pharmaceutical wanted to shortlist and prioritise ventures which provided a solution with telemonitoring capabilities, that connects patients suffering from heart failure and physicians (cardiologists). Ventures of interest needed to meet 8 criteria, including having a proven solution in market, be relatively mature (Series A or higher) and be GDPR compliant
Evaluating a corporate’s major competitors in Digital Health in Asia Pac
An APAC focused insurer wanted to analyse other insurers in the region, in order to identify their competitors key areas of focus, and determine a ‘follow’ or differentiation strategy
Related research
Evidence behind the market
Sectors
Designed for healthcare decisions
- Biopharma
- Medical device
- Health systems
- Insurance
- Corporate innovation teams
- Investors
FAQ
Common questions
What is a digital health innovation strategy?
It is a set of evidence-led choices about where digital health can create strategic value, which capabilities to pursue, how to access them, and how initiatives will be governed and measured.
How does it differ from an innovation roadmap?
The strategy defines the choices and logic. The roadmap sequences the initiatives, resources, dependencies, and decision points used to deliver those choices.
Can the work include an existing partnership portfolio?
Yes. Existing pilots, vendors, investments, and partnerships can be assessed for strategic fit, maturity, overlap, risk, and readiness to scale.
Related capabilities
Explore other decision areas
Your decision context
Bring us the question that needs a defensible answer.
We will help define the evidence, scope, and practical route from analysis to action.